PROCEPT BioRobotics annual stock-based compensation
2020
2021
2022
2023
2024
2025
PROCEPT BioRobotics Stock-Based Compensation Growth & History (PRCT)
PROCEPT BioRobotics's stock-based compensation was $47.6M for fiscal 2025.
View full PROCEPT BioRobotics company overviewPROCEPT BioRobotics annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $47.6M | $15.8M | +49.51% |
| 2024 | 2024-12-31 | $31.8M | $12.7M | +66.41% |
| 2023 | 2023-12-31 | $19.1M | $8.8M | +85.10% |
| 2022 | 2022-12-31 | $10.3M | $6.5M | +172.31% |
| 2021 | 2021-12-31 | $3.8M | $1.6M | +74.69% |
| 2020 | 2020-12-31 | $2.2M | — | — |
PROCEPT BioRobotics quarterly stock-based compensation
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $14.5M | $2.4M | +19.49% |
| Q1 2026 | 2026-03-31 | $13.1M | $3.0M | +29.32% |
| Q4 2025 | 2025-12-31 | $10.8M | $1.8M | +19.34% |
| Q3 2025 | 2025-09-30 | $14.5M | $6.0M | +70.21% |
| Q2 2025 | 2025-06-30 | $12.2M | $4.2M | +52.30% |
| Q1 2025 | 2025-03-31 | $10.1M | $3.9M | +61.57% |
| Q4 2024 | 2024-12-31 | $9.1M | $4.1M | +82.39% |
| Q3 2024 | 2024-09-30 | $8.5M | $3.2M | +59.84% |
| Q2 2024 | 2024-06-30 | $8.0M | $2.9M | +56.50% |
| Q1 2024 | 2024-03-31 | $6.3M | $2.5M | +67.99% |
| Q4 2023 | 2023-12-31 | $5.0M | $2.1M | +72.65% |
| Q3 2023 | 2023-09-30 | $5.3M | $2.1M | +65.20% |
| Q2 2023 | 2023-06-30 | $5.1M | $2.4M | +90.70% |
| Q1 2023 | 2023-03-31 | $3.7M | $2.2M | +139.95% |
| Q4 2022 | 2022-12-31 | $2.9M | $1.4M | +92.85% |
| Q3 2022 | 2022-09-30 | $3.2M | $2.3M | +248.54% |
| Q2 2022 | 2022-06-30 | $2.7M | $2.0M | +269.10% |
| Q1 2022 | 2022-03-31 | $1.6M | $902,000 | +138.77% |
| Q4 2021 | 2021-12-31 | $1.5M | — | — |
| Q3 2021 | 2021-09-30 | $925,000 | $362,000 | +64.30% |
| Q2 2021 | 2021-06-30 | $725,000 | — | — |
| Q1 2021 | 2021-03-31 | $650,000 | — | — |
| Q3 2020 | 2020-09-30 | $563,000 | — | — |
PROCEPT BioRobotics stock-based compensation trends
Over the last five fiscal years, PROCEPT BioRobotics's stock-based compensation increased from $2.2M to $47.6M, a change of $45.4M. The latest reported quarter, Q2 2026, shows $14.5M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PROCEPT BioRobotics source filings ↗